Dashboard
Manage Tickers

EYPTEyePoint Pharmaceuticals, Inc.

Nasdaq eyepointpharma.com


$ 12.67 $ 1.11 (9.6 %)    

Thursday, 09-May-2024 15:59:56 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 441.33 $ 0.96 (0.22 %)
DIA $ 394.43 $ 3.52 (0.9 %)
SPY $ 520.56 $ 2.98 (0.58 %)
TLT $ 90.69 $ 0.44 (0.49 %)
GLD $ 216.93 $ 3.37 (1.58 %)
$ 12.67
$ 12.26
$ 0.00 x 0
$ 0.00 x 0
$ 11.81 - $ 12.91
$ 5.67 - $ 30.99
2,110,475
na
670.41M
$ 1.23
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 03-08-2024 12-31-2023 10-K
3 11-03-2023 09-30-2023 10-Q
4 08-04-2023 06-30-2023 10-Q
5 05-04-2023 03-31-2023 10-Q
6 03-10-2023 12-31-2022 10-K
7 11-04-2022 09-30-2022 10-Q
8 08-05-2022 06-30-2022 10-Q
9 05-06-2022 03-31-2022 10-Q
10 03-12-2022 12-31-2021 10-K
11 11-05-2021 09-30-2021 10-Q
12 08-06-2021 06-30-2021 10-Q
13 05-05-2021 03-31-2021 10-Q
14 03-12-2021 12-31-2020 10-K
15 11-06-2020 09-30-2020 10-Q
16 08-05-2020 06-30-2020 10-Q
17 05-08-2020 03-31-2020 10-Q
18 03-16-2020 12-31-2019 10-K
19 11-07-2019 09-30-2019 10-Q
20 08-07-2019 06-30-2019 10-Q
21 05-10-2019 03-31-2019 10-Q
22 11-09-2018 09-30-2018 10-Q
23 09-18-2018 06-30-2018 10-K
24 05-10-2018 03-31-2018 10-Q
25 02-08-2018 12-31-2017 10-Q
26 11-08-2017 09-30-2017 10-Q
27 09-13-2017 06-30-2017 10-K
28 05-08-2017 03-31-2017 10-Q
29 02-09-2017 12-31-2016 10-Q
30 11-08-2016 09-30-2016 10-Q
31 09-13-2016 06-30-2016 10-K
32 05-06-2016 03-31-2016 10-Q
33 02-09-2016 12-31-2015 10-Q
34 11-06-2015 09-30-2015 10-Q
35 09-10-2015 06-30-2015 10-K
36 05-08-2015 03-31-2015 10-Q
37 02-06-2015 12-31-2014 10-Q
38 11-07-2014 09-30-2014 10-Q
39 09-11-2014 06-30-2014 10-K
40 05-14-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

eyepoint-pharmaceuticals-q1-cash-and-investments-on-march-31-2024-of-299m-is-expected-to-provide-cash-runway-into-2026
EyePoint Pharmaceuticals' Q1 Cash And Inve...
05/08/2024 11:18:37

eyepoint-pharmaceuticals-q1-2024-gaap-eps-055-misses-042-estimate-sales-11684m-beat-9986m-estimate
EyePoint Pharmaceuticals Q1 2024 GAAP EPS ...
05/08/2024 11:17:32

baird-maintains-outperform-on-eyepoint-pharmaceuticals-lowers-price-target-to-38
Baird Maintains Outperform on EyePoint Pha...
05/08/2024 11:02:17

Baird maintains EyePoint Pharmaceuticals (NASDAQ:EYPT) with a Outperform and lowers the price target from $46 to $38.

flywire-reports-q1-loss-joins-zoominfo-inspire-medical-systems-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session
Flywire Reports Q1 Loss, Joins ZoomInfo, I...
05/08/2024 10:05:47

deep-dive-into-eyepoint-pharmaceuticals-stock-analyst-perspectives-4-ratings
Deep Dive Into EyePoint Pharmaceuticals St...
05/07/2024 17:00:17

chardan-capital-maintains-buy-on-eyepoint-pharmaceuticals-lowers-price-target-to-28
Chardan Capital Maintains Buy on EyePoint ...
05/07/2024 12:51:15

Chardan Capital analyst Daniil Gataulin maintains EyePoint Pharmaceuticals (NASDAQ:EYPT) with a Buy and lowers the price tar...

mizuho-maintains-buy-on-eyepoint-pharmaceuticals-lowers-price-target-to-30
Mizuho Maintains Buy on EyePoint Pharmaceu...
05/07/2024 11:05:07

Mizuho analyst Graig Suvannavejh maintains EyePoint Pharmaceuticals (NASDAQ:EYPT) with a Buy and lowers the price target fro...

dow-surges-over-100-points-eyepoint-pharmaceuticals-shares-plunge
Dow Surges Over 100 Points; EyePoint Pharm...
05/06/2024 19:04:00

spirit-airlines-posts-weak-results-joins-integra-lifesciences-bowlero-and-other-big-stocks-moving-lower-on-monday
Spirit Airlines Posts Weak Results, Joins ...
05/06/2024 17:05:12

crude-oil-gains-1-treehouse-foods-shares-fall-after-q1-results
Crude Oil Gains 1%; TreeHouse Foods Shares...
05/06/2024 16:48:16

why-perficient-shares-are-trading-higher-by-around-53-here-are-20-stocks-moving-in-mondays-mid-day-session
Why Perficient Shares Are Trading Higher B...
05/06/2024 16:32:34

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
05/06/2024 16:31:16

nasdaq-jumps-100-points-tyson-foods-sales-miss-views
Nasdaq Jumps 100 Points; Tyson Foods Sales...
05/06/2024 15:14:07

eyepoint-pharmaceuticals-shares-halted-on-circuit-breaker-to-the-downside-stock-now-down--409
EyePoint Pharmaceuticals Shares Halted On ...
05/06/2024 13:41:43

why-is-eyepoint-pharmaceuticals-stock-plummeting-on-monday
Why Is EyePoint Pharmaceuticals Stock Plum...
05/06/2024 13:00:29

EyePoint Pharmaceuticals reveals Phase 2 PAVIA trial results for Duravyu in non-proliferative diabetic retinopathy. Positive da...

Core News & Articles
Market-Moving News for May 6th
05/06/2024 12:44:41

EYPT: -42% | EyePoint Pharmaceuticals shares are trading lower after the company's Phase 2 PAVIA trial of DURAVYU did not m...

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
05/06/2024 12:06:38

eyepoint-pharmaceuticals-announces-announces-phase-2-pavia-trial-of-duravyu-did-not-meet-pre-specified-primary-endpoint
EyePoint Pharmaceuticals Announces Announc...
05/06/2024 11:38:49

trading-halt-halt-status-updated-at-72500-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 7:25:...
05/06/2024 11:25:06

eyepoint-pharmaceuticals-announces-topline-data-from-the-phase-2-pavia-trial-of-duravyu-in-non-proliferative-diabetic-retinopathy
EyePoint Pharmaceuticals Announces Topline...
05/06/2024 11:03:20

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a company committed to developing and commercializing therapeutics to improve the...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION